ESTA - Establishment Labs Holdings Inc Stock Price, Fair Value and News

51.03USD+0.28 (+0.55%)Market Closed

Market Summary

USD51.03+0.28

Market Closed

0.55%

ESTA Stock Price

View Fullscreen

ESTA RSI Chart

ESTA Valuation

Market Cap

1.4B

Price/Earnings (Trailing)

-17.59

Price/Sales (Trailing)

8.36

EV/EBITDA

-24.15

Price/Free Cashflow

-14.32

ESTA Price/Sales (Trailing)

ESTA Profitability

Operating Margin

64.78%

EBT Margin

-47.58%

Return on Equity

-426.76%

Return on Assets

-29.22%

Free Cashflow Yield

-6.98%

ESTA Fundamentals

ESTA Revenue

Revenue (TTM)

165.2M

Rev. Growth (Yr)

-27.97%

Rev. Growth (Qtr)

-18.04%

ESTA Earnings

Earnings (TTM)

-78.5M

Earnings Growth (Yr)

-51.47%

Earnings Growth (Qtr)

29.83%

Breaking Down ESTA Revenue

Last 7 days

-6.3%

Last 30 days

0.7%

Last 90 days

43.2%

Trailing 12 Months

-32.4%

How does ESTA drawdown profile look like?

ESTA Financial Health

Current Ratio

3.06

Debt/Equity

10.07

Debt/Cashflow

-0.48

ESTA Investor Care

Shares Dilution (1Y)

11.41%

Diluted EPS (TTM)

-3.06

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2023	169.8M	177.1M	177.4M	165.2M
2022	134.8M	144.0M	153.2M	161.7M
2021	90.5M	112.1M	118.3M	126.7M
2020	93.3M	82.1M	82.0M	84.7M
2019	67.2M	75.1M	81.7M	89.6M
2018	41.3M	47.9M	54.6M	61.2M
2017	0	0	0	34.7M

Get all data in R, Python etc through our Historical Stock Data APIs

GRUFITY'S FAIR VALUE MODEL

Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed Russell 2000 Index

Small Caps and Mid Caps are mostly overlooked by investors as all the focus goes to Magnificent 7. These stocks that are not part of the beauty contest require a deeper look. However, all large cap stocks were once small caps. Grufity's Fair Value model opens up this unverse as it separates high-performing, rewarding stocks from low-performing risky stocks. <b>Russell 2000 stocks that were marked 'Very Cheap' by the model doubled in three years while the index was flat.</b>

Returns of $10,000 invested in:

Very Cheap Stocks: $21,859
Russell 2000 Index: $10,334
Very Expensive Stocks: $8,224

Russell 2000 stocks considered 'Very Cheap' by the model greatly outperformed Russell 2000 index and the 'Very Expensive' bucket over past three years.

Russell 2000 Index

Very Expensive Stocks

Very Cheap Stocks

Try For Just $1.99

Tracking the Latest Insider Buys and Sells of Establishment Labs Holdings Inc

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
Apr 10, 2024	denhoy raj	sold (taxes)	-16,701	53.19	-314	chief financial officer
Mar 31, 2024	lewin nicholas sheridan	acquired	24,991	50.9	491	-
Mar 31, 2024	custin ann	acquired	19,342	50.9	380	-
Mar 31, 2024	condon dennis e	acquired	14,964	50.9	294	-
Mar 31, 2024	schutter edward j	acquired	18,731	50.9	368	-
Mar 31, 2024	slotkin bryan	acquired	16,237	50.9	319	-
Mar 31, 2024	gillin leslie	acquired	15,575	50.9	306	-
Mar 06, 2024	chacon quiros juan jose	acquired	-	-	13,519	chief executive officer
Mar 06, 2024	denhoy raj	sold (taxes)	-15,218	49.25	-309	chief financial officer
Mar 06, 2024	denhoy raj	acquired	-	-	5,644	chief financial officer

Which funds bought or sold ESTA recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
Apr 12, 2024	Fourth Sail Capital LP	sold off	-100	-14,472,600	-	-%
Apr 10, 2024	STABLEFORD CAPITAL II LLC	new	-	1,568,480	1,568,480	0.63%
Apr 05, 2024	CWM, LLC	reduced	-21.15	2,081,000	5,863,000	0.03%
Mar 11, 2024	VANGUARD GROUP INC	reduced	-2.37	-1,696,080	1,801,630	-%
Mar 01, 2024	GOLDMAN SACHS GROUP INC	added	125	327,983	2,051,420	-%
Feb 26, 2024	PERCEPTIVE ADVISORS LLC	reduced	-70.36	-11,495,200	2,130,720	0.05%
Feb 21, 2024	FINDELL CAPITAL MANAGEMENT LLC	new	-	14,679,600	14,679,600	9.24%
Feb 16, 2024	GSA CAPITAL PARTNERS LLP	new	-	520,000	520,000	0.04%
Feb 15, 2024	BARCLAYS PLC	reduced	-72.43	-506,000	86,000	-%
Feb 15, 2024	Exome Asset Management LLC	new	-	714,564	714,564	0.71%

Are Funds Buying or Selling ESTA?

Are funds buying ESTA calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own ESTA

No. of Funds

Unveiling Establishment Labs Holdings Inc's Major ShareHolders

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Feb 14, 2024	rtw investments, lp	9.7%	2,494,138	SC 13G/A
Feb 14, 2024	nantahala capital management, llc	9.5%	2,470,154	SC 13G/A
Feb 09, 2024	chacon quiros juan jose	5.6%	1,439,943	SC 13G
Feb 09, 2024	brown advisory inc	9.3%	2,398,166	SC 13G/A
Feb 14, 2023	pura vida investments, llc	4.12%	1,002,767	SC 13G/A
Feb 14, 2023	rtw investments, lp	9.8%	2,374,138	SC 13G/A
Feb 14, 2023	nantahala capital management, llc	7.9%	1,915,023	SC 13G/A
Feb 09, 2023	brown advisory inc	6%	1,463,998	SC 13G/A
Jan 20, 2023	chacon quiros juan jose	5.8%	1,401,132	SC 13G/A
Feb 14, 2022	pura vida investments, llc	5.50%	1,319,398	SC 13G/A

Recent SEC filings of Establishment Labs Holdings Inc

View All Filings

Date Filed	Form Type	Document
Apr 12, 2024	ARS	ARS
Apr 12, 2024	DEF 14A	DEF 14A
Apr 12, 2024	DEFA14A	DEFA14A
Apr 11, 2024	4	Insider Trading
Apr 05, 2024	4/A	Insider Trading
Apr 02, 2024	4	Insider Trading
Apr 02, 2024	8-K	Current Report
Apr 02, 2024	4	Insider Trading
Apr 02, 2024	4	Insider Trading
Apr 02, 2024	4	Insider Trading

Peers (Alternatives to Establishment Labs Holdings Inc)

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
ABT	188.9B	40.1B	-9.21%	5.29%	33.01	4.71	-8.12%	-17.45%
BDX	67.8B	19.5B	-1.55%	-8.27%	53.97	3.48	4.02%	-22.04%
ALGN	22.9B	3.9B	-1.72%	-7.67%	51.41	5.92	3.42%	23.09%
BAX	20.3B	14.8B	-5.55%	-6.65%	7.66	1.37	2.12%	209.17%
MID-CAP
HSIC	9.1B	12.3B	-5.72%	-13.98%	21.85	0.74	-2.44%	-22.68%
ATR	9.1B	3.5B	-2.81%	14.53%	31.84	2.6	4.97%	18.89%
BIO	8.8B	2.7B	-10.75%	-38.18%	-13.77	3.29	-4.68%	82.43%
XRAY	6.4B	4.0B	-8.29%	-23.99%	-47.62	1.62	1.10%	85.84%
AXNX	3.4B	366.4M	-0.38%	19.00%	-565.84	9.37	33.86%	89.83%
PDCO	2.3B	6.6B	-5.95%	-4.86%	11.73	0.35	2.78%	-0.87%
SMALL-CAP
AHCO	1.3B	3.2B	-4.92%	-19.00%	-1.94	0.41	7.73%	-1066.14%
ANIK	376.4M	166.7M	-1.34%	-7.94%	-4.55	2.26	6.67%	-456.34%
ANGO	253.5M	324.0M	14.75%	-32.34%	-1.32	0.78	-3.19%	-337.41%
APYX	50.6M	52.3M	-18.86%	-53.44%	-2.7	0.97	17.61%	19.28%
AEMD	4.0M	3.7M	-9.04%	297.37%	-0.32	1.06	5.77%	8.23%

Establishment Labs Holdings Inc News

Latest updates

Establishment Labs Holdings Inc Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)

(*) denotes actual numbers (not divided by Thousands)
Income Statement (Quarterly)																					(In Thousands)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4
Revenue	-18.0%	31,560,000	38,506,000	48,561,000	46,524,000	43,813,000	38,245,000	41,190,000	38,452,000	35,313,000	29,039,000	31,994,000	30,336,000	26,963,000	22,758,000	10,474,000	24,481,000	24,249,000	22,854,000	21,684,000	20,778,000	16,397,000
Cost Of Revenue	-11.9%	10,975,000	12,454,000	18,300,000	16,445,000	15,648,000	12,205,000	13,736,000	13,516,000	11,087,000	9,419,000	10,526,000	10,246,000	12,319,000	7,612,000	3,240,000	9,003,000	7,890,000	8,616,000	8,672,000	9,526,000	6,524,000
Gross Profit	-21.0%	20,585,000	26,052,000	30,261,000	30,079,000	28,165,000	26,040,000	27,454,000	24,936,000	24,226,000	19,620,000	21,468,000	20,090,000	14,644,000	15,146,000	7,234,000	15,478,000	16,359,000	14,238,000	13,012,000	11,252,000	9,873,000
Operating Expenses	-9.3%	42,700,000	47,090,000	43,974,000	38,239,000	41,325,000	36,557,000	37,860,000	30,511,000	33,592,000	28,664,000	26,102,000	22,186,000	22,661,000	17,737,000	16,837,000	23,183,000	20,764,000	23,003,000	22,395,000	19,640,000	18,494,000
S&GA Expenses	-7.7%	36,880,000	39,962,000	37,027,000	31,706,000	34,846,000	31,268,000	32,957,000	26,913,000	27,558,000	24,780,000	21,753,000	18,138,000	18,195,000	15,008,000	14,438,000	18,984,000	17,134,000	19,227,000	18,394,000	16,056,000	14,833,000
R&D Expenses	-18.4%	5,820,000	7,128,000	6,947,000	6,533,000	6,479,000	5,289,000	4,903,000	3,598,000	6,034,000	3,884,000	4,349,000	4,048,000	4,466,000	2,729,000	2,399,000	4,199,000	3,630,000	3,776,000	4,001,000	3,584,000	3,661,000
EBITDA Margin	-23.4%	-0.38	-0.31	-0.25	-0.38	-0.38	-0.40	-0.42	-0.22	-0.24	-0.20	-0.11	-0.20	-	-	-	-	-	-	-	-	-
Interest Expenses	17.9%	4,338,000	3,679,000	3,620,000	3,756,000	2,200,000	3,880,000	3,388,000	2,292,000	2,326,000	2,293,000	2,248,000	2,195,000	2,211,000	2,886,000	2,130,000	2,146,000	2,128,000	1,805,000	2,521,000	2,242,000	2,266,000
Income Taxes	-474.4%	-2,505,000	669,000	925,000	830,000	819,000	603,000	564,000	399,000	788,000	66,000	408,000	165,000	-502,000	181,000	194,000	231,000	253,000	308,000	35,000	44,000	152,000
Earnings Before Taxes	19.4%	-23,047,000	-28,604,000	-15,820,000	-11,112,000	-12,743,000	-18,005,000	-36,542,000	-5,534,000	-13,403,000	-14,612,000	-4,914,000	-6,783,000	-6,153,000	-4,064,000	-10,278,000	-17,522,000	-5,303,000	-12,467,000	-9,005,000	-10,735,000	-10,362,000
EBT Margin	-23.6%	-0.48	-0.38	-0.33	-0.46	-0.45	-0.48	-0.49	-0.29	-0.31	-0.27	-0.20	-0.30	-	-	-	-	-	-	-	-	-
Net Income	29.8%	-20,542,000	-29,273,000	-16,745,000	-11,942,000	-13,562,000	-18,608,000	-37,106,000	-5,933,000	-14,191,000	-14,678,000	-5,322,000	-6,948,000	-5,651,000	-4,245,000	-10,472,000	-17,753,000	-5,556,000	-12,775,000	-9,040,000	-10,779,000	-10,514,000
Net Income Margin	-17.9%	-0.48	-0.40	-0.34	-0.48	-0.47	-0.50	-0.50	-0.30	-0.32	-0.28	-0.20	-0.30	-	-	-	-	-	-	-	-	-
Free Cashflow	75.0%	-8,803,000	-35,215,000	-31,357,000	-21,046,000	-14,982,000	-22,460,000	-11,937,000	-5,638,000	-7,467,000	-13,418,000	-1,714,000	-7,358,000	-	-	-	-	-	-	-	-	-

Balance Sheet

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Balance Sheet																					(In Millions)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4
Assets	-0.7%	269	271	285	209	211	188	200	142	140	148	152	152	156	155	157	168	117	118	105	109	117
Current Assets	-6.3%	175	187	209	142	150	138	156	110	113	125	128	128	132	134	136	148	96.00	98.00	84.00	92.00	99.00
Cash Equivalents	-23.3%	40.00	52.00	90.00	43.00	66.00	65.00	91.00	45.00	53.00	65.00	77.00	78.00	85.00	81.00	86.00	94.00	38.00	43.00	32.00	43.00	53.00
Inventory	17.0%	79.00	68.00	56.00	46.00	37.00	32.00	27.00	29.00	28.00	27.00	24.00	22.00	23.00	28.00	29.00	26.00	29.00	26.00	27.00	24.00	25.00
Net PPE	6.3%	77.00	73.00	66.00	57.00	51.00	39.00	35.00	23.00	19.00	17.00	17.00	16.00	16.00	16.00	16.00	16.00	16.00	17.00	17.00	13.00	13.00
Goodwill	0%	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Liabilities	4.2%	250	240	230	225	219	186	184	94.00	89.00	87.00	83.00	80.00	81.00	75.00	75.00	78.00	77.00	74.00	51.00	48.00	47.00
Current Liabilities	13.6%	57.00	50.00	43.00	41.00	39.00	32.00	35.00	37.00	32.00	30.00	27.00	25.00	26.00	20.00	21.00	22.00	23.00	20.00	21.00	17.00	16.00
Long Term Debt	-100.0%	-	185	182	179	175	-	-	52.00	-	51.00	51.00	50.00	50.00	49.00	49.00	-	48.00	-	-	-	-
LT Debt, Non Current	1.8%	189	185	182	179	175	-	-	52.00	-	51.00	51.00	50.00	50.00	49.00	49.00	-	48.00	-	-	-	-
Shareholder's Equity	-39.7%	18.00	30.00	55.00	-	-8.18	2.00	16.00	48.00	51.00	62.00	69.00	73.00	75.00	80.00	82.00	90.00	40.00	44.00	54.00	61.00	69.00
Retained Earnings	-6.0%	-360	-339	-310	-293	-281	-268	-249	-212	-206	-192	-177	-172	-165	-159	-155	-144	-127	-121	-108	-99.75	-88.97
Additional Paid-In Capital	5.7%	64.00	60.00	56.00	53.00	50.00	47.00	44.00	40.00	37.00	34.00	31.00	28.00	27.00	26.00	24.00	23.00	21.00	20.00	19.00	17.00	15.00
Accumulated Depreciation	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	6.00	6.00	5.00
Shares Outstanding	1.1%	26.00	26.00	26.00	24.00	24.00	25.00	24.00	24.00	24.00	24.00	24.00	24.00	-	-	-	-	-	-	-	-	-
Float	-	-	-	-	-	-	-	977	-	-	-	1,522	-	-	-	317	-	-	-	300	-	-

Cashflow (Last 12 Months)

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Cashflow (Quarterly)																					(In Thousands)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4
Cashflow From Operations	74.1%	-8,148	-31,511	-28,240	-20,614	-14,016	-21,980	-11,330	-4,840	-7,709	-12,455	-814	-6,554	3,434	-3,047	-6,095	-6,802	-4,026	-10,896	-7,063	-7,998	-8,480
Share Based Compensation	-13.1%	3,451	3,971	3,616	3,324	3,260	2,921	3,743	3,434	3,030	3,064	2,557	1,756	-	1,348	1,557	1,629	-	-	-	-	-
Cashflow From Investing	30.0%	-4,620	-6,600	-9,049	-4,278	-10,428	-4,810	-13,814	-5,739	-3,615	-1,083	-933	-1,532	-1,124	-2,153	-1,333	-949	-1,359	-741	-4,211	-1,455	-4,431
Cashflow From Financing	-86.7%	65.00	487	84,492	1,183	24,977	1,265	72,318	1,695	207	1,637	422	1,786	538	90.00	116	63,926	365	22,466	-26.00	-16.00	-60.00
Buy Backs	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

ESTA Income Statement

2023-12-31

Consolidated Statements of Operations - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Income Statement [Abstract]
Revenue	$ 165,151	$ 161,700	$ 126,682
Cost of revenue	58,174	55,105	41,278
Gross profit	106,977	106,595	85,404
Operating expenses:
Sales, general and administrative	145,575	125,984	92,229
Research and development	26,428	20,269	18,315
Total operating expenses	172,003	146,253	110,544
Loss from operations	(65,026)	(39,658)	(25,140)
Interest income	1,020	87	23
Interest expense	(15,393)	(11,760)	(9,062)
Change in fair value of derivative instruments	0	703	737
Loss on extinguishment of debt	0	(19,019)	0
Other income (expense), net	816	(3,177)	(6,270)
Loss before income taxes	(78,583)	(72,824)	(39,712)
Benefit (provision) for income taxes	81	(2,385)	(1,427)
Net loss	$ (78,502)	$ (75,209)	$ (41,139)
Basic net loss per share (in dollars per share)	$ (3.07)	$ (3.08)	$ (1.72)
Diluted net loss per share (in dollars per share)	$ (3.07)	$ (3.08)	$ (1.72)
Weighted average outstanding shares used for basic net loss per share (in shares)	25,600,029	24,457,793	23,972,722
Weighted average outstanding shares used for diluted net loss per share (in shares)	25,600,029	24,457,793	23,972,722

ESTA Balance Sheet

2023-12-31

Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Current assets:
Cash and cash equivalents	$ 40,035	$ 66,355
Accounts receivable, net of allowance for doubtful accounts of $1,841 and $741 at December 31, 2023 and 2022, respectively	46,918	35,423
Inventory, net	79,471	36,583
Prepaid expenses and other current assets	8,477	11,543
Total current assets	174,901	149,904
Long-term assets:
Property and equipment, net of accumulated depreciation	77,205	51,092
Goodwill	465	465
Intangible assets, net of accumulated amortization	7,987	4,608
Right-of-use operating lease assets, net	3,381	3,702
Other non-current assets	4,702	1,290
Total assets	268,641	211,061
Current liabilities:
Accounts payable	41,624	20,034
Accrued liabilities	13,690	17,237
Other liabilities, short-term	1,836	1,688
Total current liabilities	57,150	38,959
Long-term liabilities:
Note payable, Oaktree, net of debt discount and issuance costs	188,739	175,461
Operating lease liabilities, non-current	2,712	3,200
Other liabilities, long-term	1,645	1,626
Total liabilities	250,246	219,246
Commitments and contingencies (Note 14)
Shareholders’ equity (deficit):
Common shares – zero par value, unlimited amount of shares authorized at December 31, 2023 and 2022; 26,495,250 and 24,815,908 shares issued at December 31, 2023 and 2022, respectively; 26,087,180 and 24,407,838 shares outstanding at December 31, 2023 and 2022, respectively	315,634	223,637
Additional paid-in-capital	63,748	49,911
Treasury shares, at cost, 408,070 shares held at December 31, 2023 and 2022	(2,854)	(2,854)
Accumulated deficit	(360,096)	(281,594)
Accumulated other comprehensive income	1,963	2,715
Total shareholders’ equity (deficit)	18,395	(8,185)
Total liabilities and shareholders’ equity (deficit)	$ 268,641	$ 211,061

About Establishment Labs Holdings Inc

Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under Motiva Implants brand name. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander. The company sells its products through distributors and direct sales force in Europe, the Middle East, Latin America, and Asia. Establishment Labs Holdings Inc. was incorporated in 2004 and is headquartered in Alajuela, Costa Rica.

CEO	Mr. Juan Jose Chacon Quiros
WEBSITE	establishmentlabs.com
INDUSTRY	Medical Instruments & Supplies
EMPLOYEES	958

Establishment Labs Holdings Inc Frequently Asked Questions

What is the ticker symbol for Establishment Labs Holdings Inc? What does ESTA stand for in stocks?

ESTA is the stock ticker symbol of Establishment Labs Holdings Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Establishment Labs Holdings Inc (ESTA)?

As of Fri Apr 12 2024, market cap of Establishment Labs Holdings Inc is 1.38 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of ESTA stock?

You can check ESTA's fair value in chart for subscribers.

What is the fair value of ESTA stock?

You can check ESTA's fair value in chart for subscribers. The fair value of Establishment Labs Holdings Inc is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Establishment Labs Holdings Inc is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for ESTA so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Establishment Labs Holdings Inc a good stock to buy?

The fair value guage provides a quick view whether ESTA is over valued or under valued. Whether Establishment Labs Holdings Inc is cheap or expensive depends on the assumptions which impact Establishment Labs Holdings Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for ESTA.

What is Establishment Labs Holdings Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Fri Apr 12 2024, ESTA's PE ratio (Price to Earnings) is -17.59 and Price to Sales (PS) ratio is 8.36. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. ESTA PE ratio will change depending on the future growth rate expectations of investors.